150 related articles for article (PubMed ID: 6111933)
21. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
Shiu MF; Ireland MA; Littler WA
Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
[TBL] [Abstract][Full Text] [Related]
22. Hemodynamic and cardiometabolic effects of prenalterol in patients with gram negative septic shock.
Reiz S; Friedman A
Acta Anaesthesiol Scand; 1980; 24(1):5-10. PubMed ID: 7376804
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
Awan NA; Needham KE; Evenson MK; Win A; Mason DT
Am Heart J; 1981 Feb; 101(2):158-61. PubMed ID: 7468416
[TBL] [Abstract][Full Text] [Related]
24. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
25. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
Ek L; Björkman JA; Carlsson E; Johansson B
Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
[TBL] [Abstract][Full Text] [Related]
26. Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation.
Branzi A; Specchia S; Binetti G; Magelli C; Zannoli R; Magnani B
Eur Heart J; 1983 Apr; 4(4):252-8. PubMed ID: 6684041
[TBL] [Abstract][Full Text] [Related]
27. Haemodynamic effects of prenalterol in patients with coronary heart disease.
Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
[TBL] [Abstract][Full Text] [Related]
28. Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.
Pedersen T; Cleemann-Rasmussen K; Brynjolf I; Ording H; Nielsen PE; Rasmussen K
Eur J Clin Pharmacol; 1983; 25(3):287-92. PubMed ID: 6628515
[TBL] [Abstract][Full Text] [Related]
29. Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in man.
Sorbini CA; Grassi V; Tantucci C; Corea L; Bentivoglio M; Verdecchia P; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):570-5. PubMed ID: 6150902
[TBL] [Abstract][Full Text] [Related]
30. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
Tydén H; Johansson L; Nyström SO
Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
[TBL] [Abstract][Full Text] [Related]
31. Prenalterol in severe congestive heart failure. I. The immediate haemodynamic effects as compared to nitroglycerine.
Tangø M; Trap-Jensen J; Rehling M; Jespersen C; Lyngborg K
Dan Med Bull; 1988 Feb; 35(1):75-8. PubMed ID: 3125010
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
[TBL] [Abstract][Full Text] [Related]
33. Effects of prenalterol and volume loading with dextran on haemodynamics and oxygen consumption in dogs during high epidural block with special reference to the splanchnic region.
Greitz T; Andreen M; Irestedt L
Acta Anaesthesiol Scand; 1985 Jan; 29(1):37-44. PubMed ID: 2579516
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of the haemodynamic effects in man of the beta-adrenergic blocking substances Kö 1366 and practolol (author's transl)].
Gloger K
Arzneimittelforschung; 1975 Aug; 25(8):1300-3. PubMed ID: 241365
[TBL] [Abstract][Full Text] [Related]
35. Metabolic effects of prenalterol in diabetic patients.
Oltmanns D
Acta Med Scand Suppl; 1982; 659():147-55. PubMed ID: 6127885
[TBL] [Abstract][Full Text] [Related]
36. Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.
Greefhorst AP; van Herwaarden CL
Eur J Clin Pharmacol; 1983; 24(2):173-8. PubMed ID: 6132819
[TBL] [Abstract][Full Text] [Related]
37. Clinical experience of a new inotropic agent--Prenalterol--in hypotension and heart failure.
Reiz S; Waagstein F; Hjalmarson A
Clin Cardiol; 1980 Apr; 3(2):96-105. PubMed ID: 6104553
[No Abstract] [Full Text] [Related]
38. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
Kupper W; Schütt M; Bleifeld W
Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamic effects of prenalterol in healthy subjects.
Johnsson G
Acta Med Scand Suppl; 1982; 659():109-22. PubMed ID: 6127882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
